Srinivasa Raja is an Anesthesiologist in Baltimore, Maryland. Dr. Raja is rated as an Elite provider by MediFind in the treatment of Neuralgia. His top areas of expertise are Neuralgia, Chronic Pain, Acute Pain, and Complex Regional Pain Syndrome.

Eellan Sivanesan is a Pain Medicine specialist and an Anesthesiologist in Baltimore, Maryland. Dr. Sivanesan is rated as a Distinguished provider by MediFind in the treatment of Neuralgia. His top areas of expertise are Neuralgia, Chronic Pain, Complex Regional Pain Syndrome, and Shingles.

Dr. Michael Polydefkis focuses on neuromuscular diseases, particularly peripheral nerve diseases. He has a special interest in diabetic and HIV-associated peripheral neuropathy. His expertise includes nerve conduction studies, electromyography and nerve, skin and muscle biopsy reading. Dr. Michael Polydefkis received his medical degree from The Johns Hopkins University School of Medicine. He then became a Howard Hughes Medical Institute research fellow before returning to Johns Hopkins to complete an internship and residency in internal medicine, residency in neurology and a fellowship in neuromuscular diseases. Dr. Polydefkis is rated as a Distinguished provider by MediFind in the treatment of Neuralgia. His top areas of expertise are Transthyretin Amyloidosis, Familial Transthyretin Amyloidosis, Primary Amyloidosis, and Peripheral Neuropathy.

Mehtap Aygun is an Obstetrics and Gynecologist in Baltimore, Maryland. Dr. Aygun is rated as a Distinguished provider by MediFind in the treatment of Neuralgia. Her top areas of expertise are Zoon Vulvitis, Neuralgia, Endometriosis, Menorrhagia, and Intrauterine Device Insertion. Dr. Aygun is currently accepting new patients.

Jay Karri is a Physiatrist in Baltimore, Maryland. Dr. Karri is rated as a Distinguished provider by MediFind in the treatment of Neuralgia. His top areas of expertise are Chronic Pain, Neuralgia, Complex Regional Pain Syndrome, and Spasticity. Dr. Karri is currently accepting new patients.

Dr. Kristin Redmond specializes in the treatment of brain tumors and leads the spinal radiosurgery program. She received her undergraduate degree from Princeton University where she graduated magna cum laude with a focus in neuro-psychology. She attended medical school and obtained a Masters in Public Health in health systems management at Tulane University where she was elected to the Alpha Omega Alpha Honor Medical Society as well as the Gold Humanism in Medicine Honor Society. Dr. Redmonds research interest focuses on the development of novel radiation techniques and therapeutic agents to treat brain and spine tumors in order to increase tumor control and overall survival. In addition, she is working to develop innovative approaches to try to limit long term toxicities and minimize neuro-cognitive dysfunction following treatment for tumors of the central nervous system. Dr. Redmond believes in a holistic approach to medicine and feels that the social and psychological components of patient care are equally important to traditional therapies. She works closely with a team of specialists to support patients and families during their cancer journey. Make A Gift. Dr. Redmond is rated as an Advanced provider by MediFind in the treatment of Neuralgia. Her top areas of expertise are Chordoma, Brain Tumor, Astrocytoma, and Metastatic Brain Tumor.

Eric Wang is a Pain Medicine specialist and an Anesthesiologist in Baltimore, Maryland. Dr. Wang is rated as an Advanced provider by MediFind in the treatment of Neuralgia. His top areas of expertise are Chronic Pain, Neuralgia, Acute Pain, and Complex Regional Pain Syndrome.

Mohammad Khoshnoodi is a Neurologist in Baltimore, Maryland. Dr. Khoshnoodi is rated as an Advanced provider by MediFind in the treatment of Neuralgia. His top areas of expertise are Peripheral Neuropathy, Chronic Polyradiculoneuritis, Guillain-Barre Syndrome, and Miller-Fisher Syndrome.

Michael DeMarco is a Pain Medicine provider in Catonsville, Maryland. Dr. DeMarco is rated as a Distinguished provider by MediFind in the treatment of Neuralgia. His top areas of expertise are Neuralgia, Cervical Spondylosis, Spinal Stenosis, and Invertebral Disc Disease.

Dr. Ronen Shechter is an assistant professor of anesthesiology and critical care medicine at the Johns Hopkins University School of Medicine. He has expertise in managing a wide variety of chronic and acute pain conditions. He believes in a multi-modal approach to pain management that utilizes physical, behavioral, interventional and pharmacologic therapies. He is also passionate about setting realistic functional goals with his patients. Dr. Shechter earned his medical degree in 1999 from the Hebrew University Hadassah Medical School in Jerusalem. He completed his training in anesthesiology and a fellowship in pain medicine at Thomas Jefferson University Hospital and subsequently remained on the faculty in the Department of Anesthesiology there. In 2012, Dr. Shechter joined the Division of Pain Medicine in the Department of Anesthesiology and Critical Care Medicine at the Johns Hopkins University School of Medicine as a research fellow and part-time faculty member. He joined the department as a full-time assistant professor in 2014. His current research investigates a novel treatment for chemotherapy-induced nerve pain. Dr. Shechter is a faculty member in the Acute Pain Medicine and Regional Anesthesia Fellowship and the Pain Medicine Fellowship programs at the Department of Anesthesiology and Critical Care Medicine. Dr. Shechter is rated as an Advanced provider by MediFind in the treatment of Neuralgia. His top areas of expertise are Acute Pain, Neuralgia, and Chronic Pain.

Dr. Kayode Williams is an associate professor of anesthesiology and critical care medicine at the Johns Hopkins University School of Medicine and an assistant professor of business at the Carey School of Business at Johns Hopkins University. Dr. Williams earned his medical degree from the College of Medicine University of Lagos. Following training at renowned medical institutions such as the Manchester Royal Infirmary, Dr. Williams completed his residency in anesthesiology in England in 1995. Subsequently, he became a Fellow of Faculty of Anesthesia, Royal College of Surgeons in Ireland (FFARCSI). Dr. Williams joined the University of Michigan in 1997, completed a second residency training in anesthesiology in 2001, a fellowship in pain medicine in 2002, and received an M.B.A. from the University of Michigan’s Ross School of Business in 2004. Dr. Williams joined the Division of Pain Medicine in the Department of Anesthesiology and Critical Care Medicine at the Johns Hopkins School of Medicine in 2005 to develop new private practice venture, and to extend the division’s reach beyond the academic milieu and into the community. From 2009 - 2011, Dr. Williams served as the medical director at the Blaustein Pain Treatment Center at Johns Hopkins. His research focuses on translational research in neuromodulation, with emphasis on the mechanisms and efficacy of spinal cord stimulation in neuropathic pain, peripheral neuropathies and peripheral vascular disease. His interest in the business of medicine is prompted by the desire to enhance value proposition for physician groups and hospitals through effective resource management. Dr. Williams’s business focus is on specialty practice development, acute in-patient revenue cycle management and medical management consulting. Dr. Williams is rated as an Advanced provider by MediFind in the treatment of Neuralgia. His top areas of expertise are Chronic Pain, Facet Joint Syndrome, Complex Regional Pain Syndrome, and Neuralgia.

Dr. Justin McArthur is nationally and internationally recognized for his work in studying the natural history, development and treatment of the neurological complications of HIV/AIDS, multiple sclerosis and other neurological infections and immune-mediated neurological disorders. Dr. McArthur has also developed a technique to use cutaneous nerves to study sensory neuropathies, including those associated with chemotherapy, HIV and diabetes. Currently his clinical practice includes neuroimmunological disorders including MS, neurological infections, and complex undiagnosed neurological disorders. Dr. McArthur was the founding director of the Johns Hopkins/National Institute of Mental Health Research Center for HIV-associated Cognitive Disorders. The Center is an experienced interdisciplinary research team who have pooled their talents to study the nature of HIV-associated cognitive disorders. he is also the founding director of the Johns Hopkins Sheikh Khalifa Stroke institute. Dr. McArthur received his medical degree from Guys Hospital Medical School in London, UK. He then completed an internship and residency in internal medicine at The Johns Hopkins Hospital in Baltimore, MD. Dr. McArthur stayed with Johns Hopkins to complete a residency in neurology and achieve his Master's in public health. He is the current Director of the Johns Hopkins Department of Neurology and holds the John W. Griffin Professorship in neurology which was established in 2015 by Jeffrey and Harriet Legum. In April 2017 Dr. McArthur was elected to the Association of American Physicians. In 2020 he was inducted into the National Academy of Medicine. Dr. Mcarthur is rated as an Experienced provider by MediFind in the treatment of Neuralgia. His top areas of expertise are Progressive Multifocal Leukoencephalopathy, Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), and Encephalitis.

Dr. Ahmet Hoke is Professor of Neurology and Neuroscience, W. W. Smith Charitable Trust Professor of Neuroimmunology at Johns Hopkins School of Medicine, Director of the Daniel B. Drachman Division of Neuromuscular Diseases and Director of the Merkin Peripheral Neuropathy and Nerve Regeneration Center at Johns Hopkins University School of Medicine. He completed his medical training at Hacettepe University School of Medicine in Ankara, Turkey followed by his PhD studies in developmental neuroscience at Case Western Reserve University in Cleveland, Ohio, and neurology residency at Johns Hopkins Hospital. After completing his neuromuscular training at University of Calgary, Canada, he returned to Johns Hopkins University as faculty and rose through the ranks. He is the recipient of several awards including Derek Denny Brown Young Neurological Scholar Award (2005) and Wolfe Neuropathy Research prize (2018) given by the American Neurological Association, Myung Memorial Lecture Award (2017) by the Korean Neurological Association, Nejat Eczacibasi Medical Scientist Award (2019) by the Eczacibasi Foundation, Turkey, and Alan J. Gebhart Prize in Excellence in Neuropathy Research (2022) by the Peripheral Nerve Society. He is an Ex-Officio member of the Board of Directors of the American Neurological Association, and Vice-President of the Toxic Neuropathy Consortium. He serves on several editorial boards and is the Editor-in-Chief of Annals of Clinical and Translational Neurology. Dr. Hoke is rated as an Experienced provider by MediFind in the treatment of Neuralgia. His top areas of expertise are Wallerian Degeneration, Peripheral Neuropathy, Tomaculous Neuropathy, Spinal Muscular Atrophy with Arthrogryposis, and Prostatectomy.

Christopher Jackson is a neurosurgeon who specializes in brain tumors and cerebrovascular disorders, including glioma, meningioma, acoustic neuroma, trigeminal neuralgia, brain metastasis, arteriovenous malformation, and aneurysms. He is the director of the Acoustic Neuroma Center. Dr. Jackson earned his medical degree from the Johns Hopkins University School of Medicine, where he also completed his neurosurgical residency. During his residency, Dr. Jackson was honored with multiple distinctions, including the Frank L. Coulson Jr. Award for Clinical Excellence, the Irving J. Sherman Award for Resident Achievement, the Harvey Cushing Hunterian Research Award, and was elected to Alpha Omega Alpha. Dr. Jackson is an active researcher who has published over 35 peer-reviewed articles on brain tumor and cerebrovascular immunology. His laboratory focuses on how brain tumors evade the immune system and become resistant to immunotherapy. Additionally, Dr. Jackson’s laboratory explores the formation of cerebral aneurysms and inflammatory complications of cerebral aneurysm rupture. Dr. Jackson is rated as an Experienced provider by MediFind in the treatment of Neuralgia. His top areas of expertise are Trigeminal Neuralgia, Meningioma, Dysembryoplastic Neuroepithelial Tumors (DNET), Rhizotomy, and Microvascular Decompression.

Dr. Allan Belzberg is a neurosurgeon specializing in surgery of the peripheral nervous system. As Director of Peripheral Nerve Surgery at Johns Hopkins in Baltimore, he treats tumors including schwannoma, neurofibroma and nerve sheath tumor. Dr. Belzberg performs surgical repair of nerve damage caused by trauma as well as neurosurgery on carpal tunnel, peroneal nerve and other peripheral nerve conditions. Dr. Belzberg also directs the Brachial Plexus and Peripheral Nerve Clinic at the Kennedy Krieger Institute and co-directs the Neurosurgery Pain Research Institute at Johns Hopkins Hospital. Dr. Belzberg currently sees patients at the Johns Hopkins Outpatient Center located in Baltimore on Wednesdays and the Green Spring Station location on Fridays. Dr. Belzberg is rated as an Experienced provider by MediFind in the treatment of Neuralgia. His top areas of expertise are Schwannomatosis, Neurofibromatosis, Thoracic Outlet Syndrome, Osteotomy, and Rhizotomy.

With fellowship training in neuro-ophthalmology and additional training in neuro-vestibular disorders, Dr. Daniel Gold sees patients with neuro-ophthalmic disorders (affecting vision, eyelids, pupils, or causing nystagmus or double vision) in addition to oto-neurologic disorders (causing dizziness and vertigo). Videos 2018 Best Consulting Physician Award Tele-(Dizzy) Medicine. Dr. Gold is rated as an Experienced provider by MediFind in the treatment of Neuralgia. His top areas of expertise are Vertigo, Benign Paroxysmal Positional Vertigo, Brown Syndrome, and Stiff Person Syndrome.

Dr. Brett Morrison specializes in neuromuscular disorders in adults including peripheral neuropathies, amyotrophic lateral sclerosis, myasthenia gravis and muscle diseases. Dr. Morrison is currently the site principal investigator for clinical trials investigating new treatments for chronic inflammatory demyelinating polyneuropathy (CIDP) and painful diabetic peripheral neuropathy. Dr. Morrison's research interests include investigations into the mechanisms of nerve regeneration and common peripheral neuropathies. Current research focuses on better understanding the role of the immune system in peripheral nerves and targeting these pathways for the development of new treatments. Dr. Brett Morrison received his M.D. and Ph.D. from Mount Sinai Medical School in New York City. He completed his medical internship at the University of Maryland and residency in neurology at The Johns Hopkins Hospital. He then completed a fellowship in Clinical Neurophysiology at The Johns Hopkins Hospital. Dr. Morrison is rated as an Experienced provider by MediFind in the treatment of Neuralgia. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal and Bulbar Muscular Atrophy, Spinal Muscular Atrophy Type 3, and Spinal Muscular Atrophy (SMA).

Dr. Jaishri Blakeley is the Marjorie Bloomberg Tiven Professor of Neurofibromatosis in Neurology, Oncology, and Neurosurgery at Johns Hopkins School of Medicine, director of the Johns Hopkins Comprehensive Neurofibromatosis Center and director of the Neurofibromatosis Therapeutic Acceleration Program (NTAP). She is an active clinician-scientist specializing in the care of people with NF1, NF2, LZTR1, SMARC1 schwannomatoses, and primary brain tumors. Her research expertise in the development of clinical trials for nervous system tumors and specifically, early clinical-translational studies including tumor pharmacokinetic and pharmacodynamic investigations, imaging biomarkers for rare nervous system tumors, and incorporation of patient-focused, functional endpoints into efficacy studies. She has been the national or international leader of 7 clinical trials focused on therapies for glioblastoma, NF1 and NF2. In 2012 she cofounded the NTAP to dramatically shift the landscape of NF1 via necessary, efficient, and expert discovery, translational and clinical research. NTAP focuses on therapeutics, fosters collaboration, facilitates open and timely sharing of results, and streamlines the research process to accelerate therapies for plexiform and cutaneous neurofibromas. Through NTAP, Dr. Blakeley has supported and collaborated with more than 80 laboratories and research teams across the globe enabling meaningful therapeutic development for NF1-associated neoplasms and supporting the development of an exceptional community of clinician scientists focused on NF1 via the Francis S. Collins Scholars Program in Neurofibromatosis Clinical and Translational Research. Her research and programmatic efforts are all in the service of improving outcomes for the patients with NF1, NF2, schwannomatosis, and primary brain cancer for whom she is honored to provide care. Dr. Blakeley is rated as an Experienced provider by MediFind in the treatment of Neuralgia. Her top areas of expertise are Neurofibromatosis, Schwannomatosis, Neurofibromatosis Type 2 (NF2), Neurofibromatosis Type 1 (NF1), and Laminectomy.

Dr. Alexander Pantelyat cares for patients with movement disorders such as Parkinson's disease and related syndromes, essential tremor, dystonia, chorea and normal pressure hydrocephalus. He also provides botulinum toxin injections for movement disorders and is involved in deep brain stimulation programming and intraoperative neurophysiological monitoring.His research explores atypical parkinsonian disorders, such as dementia with Lewy bodies, progressive supranuclear palsy, corticobasal syndrome/degeneration and multiple system atrophy; cognitive aspects of movement disorders; and music-based rehabilitation of neurodegenerative diseases.Dr. Pantelyat earned his medical degree from Temple University School of Medicine in Philadelphia, where he was elected a member of the Alpha Omega Alpha Honor Medical Society and received the Matthew T. Moore Prize in Neurology. He completed his residency training in Neurology ​at the University of Pennsylvania in Philadelphia, and a fellowship in movement disorders at the University of Pennsylvania/Philadelphia VA Medical Center. As part of his fellowship, Dr. Pantelyat also completed the Clinical Research Certificate Program at the Center for Clinical Epidemiology and Biostatistics. He is a 2013 American Academy of Neurology Palatucci Advocacy Leader and grant recipient. Dr. Pantelyat is rated as an Experienced provider by MediFind in the treatment of Neuralgia. His top areas of expertise are Progressive Supranuclear Palsy, Progressive Supranuclear Palsy Atypical, Supranuclear Ophthalmoplegia, and Corticobasal Degeneration.

Daniel Lubelski is a fellowship-trained neurosurgeon with expertise in complex spine surgery and peripheral nerve surgery. He treats patients with spinal diseases and deformities, spine and nerve tumors, and brachial plexus injuries and other peripheral nerve injuries. Dr. Lubelski’s training in complex and robotic spine surgery, spinal oncology and peripheral nerve injuries allows him to comprehensively evaluate patients and develop custom treatment plans to address symptoms and improve patients’ quality of life. He prioritizes patient-centered care, effective communication and working in multidisciplinary collaboration to identify the best treatment. After obtaining his undergraduate degree at the City University of New York, Dr. Lubelski spent a year doing predoctoral research at the National Institutes of Health. He then obtained his medical degree from the Cleveland Clinic Lerner College of Medicine, and he performed stem cell tumor research as a Howard Hughes Medical Institute fellow. Dr. Lubelski went on to the Johns Hopkins University School of Medicine for a neurosurgery residency and an enfolded fellowship in peripheral nerve surgery. His postdoctoral training also included a fellowship in complex spine surgery and spinal oncology at Johns Hopkins, as well as a traveling fellowship with advanced training at the Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center. Dr. Lubelski is a prolific researcher who focuses on patient quality of life and on using big data to develop individualized prediction models to determine optimal treatments tailored to each person. He has authored more than 200 peer-reviewed papers and numerous textbook chapters, has lectured nationally and internationally, and serves as a reviewer for the top neurosurgical journals. Dr. Lubelski is rated as an Experienced provider by MediFind in the treatment of Neuralgia. His top areas of expertise are Spinal Tumor, Chordoma, Spinal Stenosis, Spinal Fusion, and Laminectomy.